Takeda Pharmaceutical Co Ltd
XMUN:TKD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
|
T
|
Thales SA
DUS:CSF
|
FR |
|
S
|
Sega Sammy Holdings Inc
XBER:RYU
|
JP |
|
R
|
Rexel SA
XMUN:E7V
|
FR |
|
C
|
Central Plaza Hotel PCL
SET:CENTEL
|
TH |
|
A
|
Acea SpA
XMUN:DCA
|
IT |
|
H
|
Healthequity Inc
F:2HE
|
US |
|
T
|
Takeda Pharmaceutical Co Ltd
XBER:TKD
|
JP |
|
F
|
Farmer Bros Co
F:FB1
|
US |
|
Maxell Ltd
OTC:MXLLF
|
JP |
|
Interpump Group SpA
MIL:IP
|
IT |
Wall St Price Targets
TKD Price Targets Summary
Takeda Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for TKD is 34.03 EUR with a low forecast of 28.3 EUR and a high forecast of 44.7 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is TKD's stock price target?
Price Target
34.03
EUR
According to Wall Street analysts, the average 1-year price target for TKD is 34.03 EUR with a low forecast of 28.3 EUR and a high forecast of 44.7 EUR.
What is the Revenue forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
3%
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 3 years is 3%.
What is the Gross Profit forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 8%. The projected CAGR for the next 2 years is 2%.
What is the Operating Income forecast for Takeda Pharmaceutical Co Ltd?
Projected CAGR
-24%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 1 year is -24%.
